Resources | NITAG RESOURCE CENTER

2021 ∙ Conseil Supérieur de la Santé (CSS)

Non-replicating viral vector vaccines and the Belgian COVID-19 vaccination strategy

2021 ∙ Conseil Supérieur de la Santé (CSS)

Prioritization of at-risk groups for SARS-CoV-2 Vaccination (Phase 1b)

2021 ∙ Conseil Supérieur de la Santé (CSS)

Recommendations for the administration of one or two doses of mRNA vaccines in people who are or have been infected with SARS-CoV-2 in Belgium - 09 June 2021

2021 ∙ Conseil Supérieur de la Santé (CSS)

Recommendations for the vaccination of children at increased risk of invasive pneumococcal disease (PID)

2021 ∙ Conseil Supérieur de la Santé (CSS)

Recommendations regarding the pediatric vaccination against SARS-CoV-2 of children aged older than 12 in Belgium

2021 ∙ Conseil Supérieur de la Santé (CSS)

Recommendations regarding the pediatric vaccination against SARS-CoV-2 of children aged older than 12 in Belgium - 9 July 2021

2021 ∙ Conseil Supérieur de la Santé (CSS)

SARS-CoV-2 vaccination recommendations for people aged 16 to 17 (part 1) in Belgium - 20 May 2021

2021 ∙ Conseil Supérieur de la Santé (CSS)

Seasonal influenza vaccination: winter season 2021-2022 (in the context of Covid-19, Belgium) - 10 June 2021

2021 ∙ Conseil Supérieur de la Santé (CSS)

Vaccination against COVID-19 in pregnant and breastfeeding women

2021

Vaccination strategy against COVID19 in Spain